{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:47:40Z","timestamp":1789850860526,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,7,19]],"date-time":"2009-07-19T00:00:00Z","timestamp":1247961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s11894-009-0040-4","type":"journal-article","created":{"date-parts":[[2009,7,18]],"date-time":"2009-07-18T08:59:19Z","timestamp":1247907559000},"page":"270-277","source":"Crossref","is-referenced-by-count":93,"title":["A role for corticotropin-releasing factor in functional gastrointestinal disorders"],"prefix":"10.1007","volume":"11","author":[{"given":"Yvette","family":"Tach\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Kiank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,19]]},"reference":[{"key":"40_CR1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","volume":"130","author":"D.A. Drossman","year":"2006","unstructured":"Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006, 130:1377\u20131390.","journal-title":"Gastroenterology"},{"issue":"Suppl1","key":"40_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2982.2008.01097.x","volume":"20","author":"N.J. Talley","year":"2008","unstructured":"Talley NJ: Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 2008, 20(Suppl 1):121\u2013129.","journal-title":"Neurogastroenterol Motil"},{"key":"40_CR3","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1053\/j.gastro.2008.05.003","volume":"134","author":"E.A. Mayer","year":"2008","unstructured":"Mayer EA: The challenge of studying the biology of complex, symptom-based GI disorders. Gastroenterology 2008, 134:1826\u20131827.","journal-title":"Gastroenterology"},{"key":"40_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ibd.20059","volume":"13","author":"D. Limsui","year":"2007","unstructured":"Limsui D, Pardi DS, Camilleri M, et al.: Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007, 13:175\u2013181.","journal-title":"Inflamm Bowel Dis"},{"key":"40_CR5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2982.2008.01220.x","volume":"21","author":"S. Kindt","year":"2009","unstructured":"Kindt S, Van Oudenhove L, Broekaert D, et al.: Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 2009, 21:389\u2013398.","journal-title":"Neurogastroenterol Motil"},{"key":"40_CR6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.coph.2008.07.012","volume":"8","author":"M. Grover","year":"2008","unstructured":"Grover M, Drossman DA: Psychotropic agents in functional gastrointestinal disorders. Curr Opin Pharmacol 2008, 8:715\u2013723.","journal-title":"Curr Opin Pharmacol"},{"key":"40_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI30085","volume":"117","author":"Y. Tach\u00e9","year":"2007","unstructured":"Tach\u00e9 Y, Bonaz B: Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007, 117:33\u201340.","journal-title":"J Clin Invest"},{"key":"40_CR8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2174\/156652408784533760","volume":"8","author":"M.G. Gareau","year":"2008","unstructured":"Gareau MG, Silva MA, Perdue MH: Pathophysiological mechanisms of stress-induced intestinal damage. Curr Mol Med 2008, 8:274\u2013281.","journal-title":"Curr Mol Med"},{"key":"40_CR9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cgh.2008.08.032","volume":"7","author":"M. Grover","year":"2009","unstructured":"Grover M, Herfarth H, Drossman DA: The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol 2009, 7:48\u201353.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"40_CR10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpsychores.2008.02.021","volume":"64","author":"A. Riedl","year":"2008","unstructured":"Riedl A, Schmidtmann M, Stengel A, et al.: Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008, 64:573\u2013582.","journal-title":"J Psychosom Res"},{"key":"40_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yhbeh.2005.01.009","volume":"48","author":"T.L. Bale","year":"2005","unstructured":"Bale TL: Sensitivity to stress: dysregulation of CRF pathways and disease development. Horm Behav 2005, 48:1\u201310.","journal-title":"Horm Behav"},{"issue":"Suppl17","key":"40_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00535-006-1942-7","volume":"42","author":"S. Fukudo","year":"2007","unstructured":"Fukudo S: Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol 2007, 42(Suppl 17):48\u201351.","journal-title":"J Gastroenterol"},{"key":"40_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","volume":"44","author":"T.L. Bale","year":"2004","unstructured":"Bale TL, Vale WW: CRF and CRF receptor: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 2004, 44:525\u2013557.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"40_CR14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1517\/14728222.11.11.1401","volume":"11","author":"S.K. Wood","year":"2007","unstructured":"Wood SK, Woods JH: Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances. Expert Opin Ther Targets 2007, 11:1401\u20131413.","journal-title":"Expert Opin Ther Targets"},{"key":"40_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1124\/pr.55.1.3","volume":"55","author":"R.L. Hauger","year":"2003","unstructured":"Hauger RL, Grigoriadis DE, Dallman MF, et al.: International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev 2003, 55:21\u201326.","journal-title":"Pharmacol Rev"},{"key":"40_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2006.09.002","volume":"28","author":"E.M. Fekete","year":"2007","unstructured":"Fekete EM, Zorrilla EP: Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs. Front Neuroendocrinol 2007, 28:1\u201327.","journal-title":"Front Neuroendocrinol"},{"key":"40_CR17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/er.2005-0034","volume":"27","author":"E.W. Hillhouse","year":"2006","unstructured":"Hillhouse EW, Grammatopoulos DK: The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 2006, 27:260\u2013286.","journal-title":"Endocr Rev"},{"key":"40_CR18","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1210\/en.2006-0565","volume":"148","author":"S.V. Wu","year":"2007","unstructured":"Wu SV, Yuan P-Q, Wang L, et al.: Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus. Endocrinology 2007, 148:1675\u20131687.","journal-title":"Endocrinology"},{"key":"40_CR19","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/me.2008-0177","volume":"22","author":"D. Markovic","year":"2008","unstructured":"Markovic D, Lehnert H, Levine MA, Grammatopoulos DK: Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d. Mol Endocrinol 2008, 22:2505\u20132519.","journal-title":"Mol Endocrinol"},{"key":"40_CR20","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1073\/pnas.0409583102","volume":"102","author":"A.M. Chen","year":"2005","unstructured":"Chen AM, Perrin MH, Digruccio MR, et al.: A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc Natl Acad Sci U S A 2005, 102:2620\u20132625.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"40_CR21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gut.2006.117549","volume":"57","author":"C. Wallon","year":"2008","unstructured":"Wallon C, Yang PC, Keita AV, et al.: Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut 2008, 57:50\u201358.","journal-title":"Gut"},{"key":"40_CR22","doi-asserted-by":"crossref","first-page":"G903","DOI":"10.1152\/ajpgi.00066.2007","volume":"293","author":"T. Kimura","year":"2007","unstructured":"Kimura T, Amano T, Uehara H, et al.: Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon. Am J Physiol Gastrointest Liver Physiol 2007, 293:G903\u2013G910.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"40_CR23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1365-2982.2007.00978.x","volume":"19","author":"P.Q. Yuan","year":"2007","unstructured":"Yuan PQ, Million M, Wu SV, et al.: Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol Motil 2007, 19:923\u2013936.","journal-title":"Neurogastroenterol Motil"},{"key":"40_CR24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2008.03967.x","volume":"1153","author":"S. Silberstein","year":"2009","unstructured":"Silberstein S, Vogl AM, Bonfiglio JJ, et al.: Immunology, signal transduction, and behavior in hypothalamic-pituitary-adrenal axis-related genetic mouse models. Ann N Y Acad Sci 2009, 1153:120\u2013130.","journal-title":"Ann N Y Acad Sci"},{"key":"40_CR25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2982.2007.00903.x","volume":"19","author":"J. Tayama","year":"2007","unstructured":"Tayama J, Sagami Y, Shimada Y, et al.: Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome. Neurogastroenterol Mot 2007, 19:471\u2013483.","journal-title":"Neurogastroenterol Mot"},{"key":"40_CR26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/156802608783955665","volume":"8","author":"J.E. Tellew","year":"2008","unstructured":"Tellew JE, Luo Z: Small molecule antagonists of the corticotropin releasing factor (CRF) receptor: recent medicinal chemistry developments. Curr Top Med Chem 2008, 8:506\u2013520.","journal-title":"Curr Top Med Chem"},{"key":"40_CR27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejphar.2007.12.032","volume":"583","author":"F. Holsboer","year":"2008","unstructured":"Holsboer F, Ising M: Central CRH system in depression and anxiety\u2014evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 2008, 583:350\u2013357.","journal-title":"Eur J Pharmacol"},{"key":"40_CR28","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2982.2007.00951.x","volume":"19","author":"N. Trimble","year":"2007","unstructured":"Trimble N, Johnson AC, Foster A, Greenwood-Van Meerveld B: Corticotropin-releasing factor receptor 1-deficient mice show decreased anxiety and colonic sensitivity. Neurogastroenterol Motil 2007, 19:754\u2013760.","journal-title":"Neurogastroenterol Motil"},{"key":"40_CR29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neubiorev.2005.03.003","volume":"29","author":"M.E. Keck","year":"2005","unstructured":"Keck ME, Ohl F, Holsboer F, Muller MB: Listening to mutant mice: a spotlight on the role of CRF\/CRF receptor systems in affective disorders. Neurosci Biobehav Rev 2005, 29:867\u2013889.","journal-title":"Neurosci Biobehav Rev"},{"key":"40_CR30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S1092852900016709","volume":"13","author":"S.M. Stahl","year":"2008","unstructured":"Stahl SM, Wise DD: The potential role of a corticotrophin-releasing factor receptor-1 antagonist in psychiatric disorders. CNS Spectr 2008, 13:467\u2013483.","journal-title":"CNS Spectr"},{"key":"40_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1196\/annals.1410.007","volume":"1148","author":"Y. Tach\u00e9","year":"2008","unstructured":"Tach\u00e9 Y, Brunnhuber S: From Hans Selye\u2019s discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases. Ann N Y Acad Sci 2008, 1148:29\u201341.","journal-title":"Ann N Y Acad Sci"},{"key":"40_CR32","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1021\/jm0202122","volume":"45","author":"J. Rivier","year":"2002","unstructured":"Rivier J, Gulyas J, Kirby D, et al.: Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 2002, 45:4737\u20134747.","journal-title":"J Med Chem"},{"key":"40_CR33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/138920306777452358","volume":"7","author":"H.P. Nazarloo","year":"2006","unstructured":"Nazarloo HP, Buttrick PM, Saadat H, Dunn AJ: The roles of corticotropin-releasing factor-related peptides and their receptors in the cardiovascular system. Curr Protein Pept Sci 2006, 7:229\u2013239.","journal-title":"Curr Protein Pept Sci"},{"key":"40_CR34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.physiol.010908.163221","volume":"71","author":"A. Stengel","year":"2009","unstructured":"Stengel A, Tach\u00e9 Y: Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol 2009, 71:219\u2013239.","journal-title":"Annu Rev Physiol"},{"key":"40_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1751-0759-2-16","volume":"2","author":"Y. Fujii","year":"2008","unstructured":"Fujii Y, Nomura S: A prospective study of the psychobehavioral factors responsible for a change from non-patient irritable bowel syndrome to IBS patient status. Biopsychosoc Med 2008, 2:16.","journal-title":"Biopsychosoc Med"},{"key":"40_CR36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2005.11.033","volume":"130","author":"T.G. Dinan","year":"2006","unstructured":"Dinan TG, Quigley EM, Ahmed SM, et al.: Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006, 130:304\u2013311.","journal-title":"Gastroenterology"},{"key":"40_CR37","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.npp.1301328","volume":"32","author":"M. Ising","year":"2007","unstructured":"Ising M, Zimmermann US, Kunzel HE, et al.: High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response. Neuropsychopharmacology 2007, 32:1941\u20131949.","journal-title":"Neuropsychopharmacology"},{"key":"40_CR38","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3748\/wjg.v13.i14.2020","volume":"13","author":"C.S. North","year":"2007","unstructured":"North CS, Hong BA, Alpers DH: Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. World J Gastroenterol 2007, 13:2020\u20132027.","journal-title":"World J Gastroenterol"},{"key":"40_CR39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1037\/1064-1297.15.6.519","volume":"15","author":"M. Ising","year":"2007","unstructured":"Ising M, Holsboer F: CRH-sub-1 receptor antagonists for the treatment of depression and anxiety. Exp Clin Psychopharmacol 2007, 15:519\u2013528.","journal-title":"Exp Clin Psychopharmacol"},{"key":"40_CR40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2008.07071199","volume":"165","author":"B. Binneman","year":"2008","unstructured":"Binneman B, Feltner D, Kolluri S, et al.: A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. Am J Psychiatry 2008, 165:617\u2013620.","journal-title":"Am J Psychiatry"},{"key":"40_CR41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/edrv-17-2-187","volume":"17","author":"F. Holsboer","year":"1996","unstructured":"Holsboer F, Barden N: Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996, 17:187\u2013205.","journal-title":"Endocr Rev"},{"key":"40_CR42","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/gut.2004.058685","volume":"54","author":"K. Tillisch","year":"2005","unstructured":"Tillisch K, Mayer EA, Labus JS, et al.: Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut 2005, 54:1396\u20131401.","journal-title":"Gut"},{"issue":"Suppl1","key":"40_CR43","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/01.psy.0000162254.61556.d5","volume":"67","author":"R.M. Carney","year":"2005","unstructured":"Carney RM, Freedland KE, Veith RC: Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005, 67(Suppl 1):S29\u2013S33.","journal-title":"Psychosom Med"},{"key":"40_CR44","doi-asserted-by":"crossref","unstructured":"Larauche M, Gourcerol G, Wang L, et al.: Cortagine, a CRF1 agonist, induces stress-like alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways. Am J Physiol Gastrointest Liver Physiol 2009 (Epub ahead of print).","DOI":"10.1152\/ajpgi.00072.2009"},{"key":"40_CR45","doi-asserted-by":"crossref","first-page":"G1037","DOI":"10.1152\/ajpgi.00419.2006","volume":"292","author":"Y. Nakade","year":"2007","unstructured":"Nakade Y, Fukuda H, Iwa M, et al.: Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1037\u2013G1044.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"40_CR46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/gut.2003.018911","volume":"53","author":"Y. Sagami","year":"2004","unstructured":"Sagami Y, Shimada Y, Tayama J, et al.: Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 2004, 53:958\u2013964.","journal-title":"Gut"},{"key":"40_CR47","doi-asserted-by":"crossref","unstructured":"Sweetser S, Camilleri M, Linker Nord SJ, et al.: Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in females with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol 2009 (Epub ahead of print).","DOI":"10.1152\/ajpgi.00011.2009"},{"key":"40_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/138161206778743637","volume":"12","author":"V. Martinez","year":"2006","unstructured":"Martinez V, Tach\u00e9 Y: CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des 2006, 12:1\u201318.","journal-title":"Curr Pharm Des"},{"key":"40_CR49","doi-asserted-by":"crossref","first-page":"G1033","DOI":"10.1152\/ajpgi.00507.2007","volume":"294","author":"M. Larauche","year":"2008","unstructured":"Larauche M, Bradesi S, Million M, et al.: Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats. Am J Physiol Gastrointest Liver Physiol 2008, 294:G1033\u2013G1040.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"40_CR50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1365-2982.2008.01151.x","volume":"20","author":"K. Saito-Nakaya","year":"2008","unstructured":"Saito-Nakaya K, Hasegawa R, Nagura Y, et al.: Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. Neurogastroenterol Motil 2008, 20:1147\u20131156.","journal-title":"Neurogastroenterol Motil"},{"key":"40_CR51","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s00535-006-1848-4","volume":"41","author":"T. Nozu","year":"2006","unstructured":"Nozu T, Kudaira M: Corticotropin-releasing factor induces rectal hypersensitivity after repetitive painful rectal distention in healthy humans. J Gastroenterol 2006, 41:740\u2013744.","journal-title":"J Gastroenterol"},{"key":"40_CR52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.gastro.2006.05.014","volume":"131","author":"B.D. Naliboff","year":"2006","unstructured":"Naliboff BD, Berman S, Suyenobu B, et al.: Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology 2006, 131:352\u2013365.","journal-title":"Gastroenterology"},{"key":"40_CR53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2005.07.010","volume":"1056","author":"H. Kosoyan","year":"2005","unstructured":"Kosoyan H, Grigoriadis D, Tach\u00e9 Y: The CRF1 antagonist, NBI-35965 abolished the activation of locus coeruleus by colorectal distention and intracisternal CRF in rats. Brain Res 2005, 1056:85\u201396.","journal-title":"Brain Res"},{"key":"40_CR54","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2982.2007.00925.x","volume":"19","author":"M. Camilleri","year":"2007","unstructured":"Camilleri M, Gorman H: Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil 2007, 19:545\u2013552.","journal-title":"Neurogastroenterol Motil"},{"key":"40_CR55","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/gut.2007.140806","volume":"58","author":"T. Piche","year":"2009","unstructured":"Piche T, Barbara G, Aubert P, et al.: Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009, 58:196\u2013201.","journal-title":"Gut"},{"key":"40_CR56","doi-asserted-by":"crossref","first-page":"G452","DOI":"10.1152\/ajpgi.90210.2008","volume":"295","author":"A.A. Teitelbaum","year":"2008","unstructured":"Teitelbaum AA, Gareau MG, Jury J, et al.: Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress. Am J Physiol Gastrointest Liver Physiol 2008, 295:G452\u2013G459.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"40_CR57","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.psyneuen.2008.07.002","volume":"33","author":"J. Santos","year":"2008","unstructured":"Santos J, Yates D, Guilarte M, et al.: Stress neuropeptides evoke epithelial responses via mast cell activation in the rat colon. Psychoneuroendocrinology 2008, 33:1248\u20131256.","journal-title":"Psychoneuroendocrinology"},{"key":"40_CR58","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11894-008-0073-0","volume":"10","author":"R. Giorgio De","year":"2008","unstructured":"De Giorgio R, Barbara G: Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep 2008, 10:385\u2013390.","journal-title":"Curr Gastroenterol Rep"},{"key":"40_CR59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/156652408784533788","volume":"8","author":"J. Santos","year":"2008","unstructured":"Santos J, Alonso C, Vicario M, et al.: Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome. Curr Mol Med 2008, 8:258\u2013273.","journal-title":"Curr Mol Med"},{"key":"40_CR60","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/gut.2006.108712","volume":"56","author":"I. Posserud","year":"2007","unstructured":"Posserud I, Stotzer PO, Bjornsson ES, et al.: Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007, 56:802\u2013808.","journal-title":"Gut"},{"key":"40_CR61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","volume":"132","author":"T. Liebregts","year":"2007","unstructured":"Liebregts T, Adam B, Bredack C, et al.: Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132:913\u2013920.","journal-title":"Gastroenterology"},{"key":"40_CR62","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ibd.20129","volume":"13","author":"K.J. Gross","year":"2007","unstructured":"Gross KJ, Pothoulakis C: Role of neuropeptides in inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:918\u2013932.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0040-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-009-0040-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0040-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:04:05Z","timestamp":1559419445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-009-0040-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,19]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s11894-009-0040-4","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,19]]}}}